Moreover, in HT-29 colon cancer cells, quercetin–resveratrol combination treatment reduced the proteins SP1, SP3, and SP4, transcription factors known to be overexpressed in colon cancer. The gene discussed is SP4; the disease is malignant colon neoplasm.